메뉴 건너뛰기




Volumn 86, Issue 12, 2004, Pages 2677-2685

Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOISOTOPE;

EID: 10344247117     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200412000-00014     Document Type: Article
Times cited : (75)

References (23)
  • 2
    • 0032616268 scopus 로고    scopus 로고
    • Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants
    • Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
    • (1999) Radiographics , vol.19 , pp. 61-77
    • Shreve, P.D.1    Anzai, Y.2    Wahl, R.L.3
  • 4
    • 0032886668 scopus 로고    scopus 로고
    • Oncological applications of FDG PET imaging
    • Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med. 1999;40:1706-15.
    • (1999) J Nucl Med , vol.40 , pp. 1706-1715
    • Delbeke, D.1
  • 8
    • 0030254972 scopus 로고    scopus 로고
    • Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
    • Cook GJ, Fogelman I, Malsey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308-14.
    • (1996) Semin Nucl Med , vol.26 , pp. 308-314
    • Cook, G.J.1    Fogelman, I.2    Malsey, M.N.3
  • 13
    • 0034049414 scopus 로고    scopus 로고
    • (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma
    • Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6:1279-87.
    • (2000) Clin Cancer Res , vol.6 , pp. 1279-1287
    • Folpe, A.L.1    Lyles, R.H.2    Sprouse, J.T.3    Conrad III, E.U.4    Eary, J.F.5
  • 14
    • 0036305306 scopus 로고    scopus 로고
    • Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies
    • D'Amico TA, Wong TZ, Harpole DH, Brown SD, Coleman RE. Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. Ann Thorac Surg. 2002;74:160-3.
    • (2002) Ann Thorac Surg , vol.74 , pp. 160-163
    • D'Amico, T.A.1    Wong, T.Z.2    Harpole, D.H.3    Brown, S.D.4    Coleman, R.E.5
  • 16
    • 0345103356 scopus 로고    scopus 로고
    • The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model
    • Chung JK, Chang YS, Lee YJ, Kim YJ, Jeong JM, Lee DS, Jang JJ, Lee MC. The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model. Ann Nucl Med. 1999;13:303-8.
    • (1999) Ann Nucl Med , vol.13 , pp. 303-308
    • Chung, J.K.1    Chang, Y.S.2    Lee, Y.J.3    Kim, Y.J.4    Jeong, J.M.5    Lee, D.S.6    Jang, J.J.7    Lee, M.C.8
  • 17
    • 0036434696 scopus 로고    scopus 로고
    • The value of positron emission tomography (PET) imaging in disease staging and therapy assessment
    • Jerusalem G, Hustinx R, Beguin Y, Fillet G. The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Ann Oncol. 2002;13 (Suppl 4):227-34.
    • (2002) Ann Oncol , vol.13 , Issue.4 SUPPL. , pp. 227-234
    • Jerusalem, G.1    Hustinx, R.2    Beguin, Y.3    Fillet, G.4
  • 20
    • 0034948354 scopus 로고    scopus 로고
    • Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)
    • Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, Fillet G. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol. 2001;12:825-30.
    • (2001) Ann Oncol , vol.12 , pp. 825-830
    • Jerusalem, G.1    Beguin, Y.2    Najjar, F.3    Hustinx, R.4    Fassotte, M.F.5    Rigo, P.6    Fillet, G.7
  • 21
    • 0029888387 scopus 로고    scopus 로고
    • Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose
    • Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology. 1996;199:751-6.
    • (1996) Radiology , vol.199 , pp. 751-756
    • Shreve, P.D.1    Grossman, H.B.2    Gross, M.D.3    Wahl, R.L.4
  • 22
    • 0030254972 scopus 로고    scopus 로고
    • Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
    • Cook GJ, Fogelman I, Malsey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308-14.
    • (1996) Semin Nucl Med , vol.26 , pp. 308-314
    • Cook, G.J.1    Fogelman, I.2    Malsey, M.N.3
  • 23
    • 0032921197 scopus 로고    scopus 로고
    • PET in lung cancer
    • Coleman RE. PET in lung cancer. J Nucl Med. 1999;40:814-20.
    • (1999) J Nucl Med , vol.40 , pp. 814-820
    • Coleman, R.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.